On April 5, 2013, an independent Institutional Review Board (IRB) approved the amended protocol and informed consent documents for our soon-to-be-initiated study of MDMA-assisted psychotherapy for PTSD …
On February 21, 2013, the U.S. Drug Enforcement Administration approved the Schedule I license for the psychiatrist for our new study of MDMA-assisted psychotherapy for PTSD in Boulder, Colorado. The Schedule …
On February 6, 2013, field agents from the Denver, Colorado, office U.S. Drug Enforcement Administration inspected the site, safe, and alarm system that will protect the approximately eight grams of MDMA …
On October 25, 2012, the zoning office for the City of Boulder, Colorado, issued the business license for the site for our upcoming study of MDMA-assisted psychotherapy for PTSD. This license was required …
On October 16, 2012, the zoning office for the city of Boulder, Colorado, approved the business license for the site for our upcoming study of MDMA-assisted psychotherapy in Boulder. The local Drug Enforcement …
On July 31, 2012, an inspector from the U.S. Drug Enforcement Administration conducted the scheduled inspection of the site for our planned study of MDMA-assisted psychotherapy for PTSD in Boulder, Colorado. …
On May 15, 2012, the U.S. Drug Enforcement Administration approved the protocol for our upcoming study of MDMA-assisted psychotherapy for PTSD, to take place in Boulder, Colorado, with Principal Investigator …
On May 4, 2012, the U.S. Food and Drug Administration notified the MAPS clinical team that our new “intern study” of MDMA-assisted psychotherapy for subjects with PTSD had been cleared for …
On May 3, 2012, an official from the Denver office of the Drug Enforcement Administration conducted an inspection of the safe and facility to be used to store the MDMA for our upcoming intern study of …
From April 8-11, 2012, the therapist teams for our MDMA-assisted psychotherapy for PTSD “intern” study completed therapist training in Charleston, South Carolina, with MDMA-assisted psychotherapy …
On March 27, the study protocol for our upcoming U.S. intern study of MDMA-assisted psychotherapy for PTSD was cleared for initiation by the FDA after we received no response during the mandated 30-day …
On March 9, the protocol for our planned U.S. intern study of MDMA-assisted psychotherapy for PTSD received approval from the Institutional Review Board, conditional on the pending approval of the study …
